Narrative review / 2020
A stepwise management approach based on lifestyle interventions and lipid-lowering therapy is proposed for low-CVD-risk individuals with elevated LDL-C.
Existing guidelines show considerable inconsistency regarding the management of patients at low overall cardiovascular disease (CVD) risk who have persistently elevated LDL-C. Authors propose a step-by-step practical approach for individuals with low (< 1%) 10-year CVD risk and elevated LDL-C (> 140 mg/dL, 3.6 mmol/L). The strategy is based on adherence to lifestyle interventions, with stepwise management including lipid-lowering therapy if non-adherent, targeting LDL-C levels < 115 mg/dL (3.0 mmol/L). The authors note further studies are needed to determine the long-term efficacy, safety, and cost-effectiveness of this approach.
- Study type
- Narrative review and proposal
- Who was studied
- Individuals with low (< 1%) 10-year CVD risk and elevated LDL-C (> 140 mg/dL)
- What was measured
- Management of cardiovascular risk and LDL-C target levels (< 115 mg/dL)
THE PAPER
LDL-C: lower is better for longer-even at low risk.
Penson PE, Pirro M, Banach M. BMC Med, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.